Clift

Clift: a cardiotonic drug for the treatment of heart failure

Clift is a cardiotonic drug used to treat heart failure. It is produced by the German company Knoll AG and has the international name Meproscillarin. The dosage form of Clift is 0.25 mg tablets.

Heart failure is a condition in which the heart cannot pump blood effectively throughout the body. This leads to poor health, reduced physical activity and an increased risk of heart disease. Cardiotonic medications, including Clift, are used to maintain heart function and improve the quality of life of patients suffering from heart failure.

Cardiotonic drugs are a group of drugs that improve the contractile function of the heart. They work by increasing the force of contraction of the heart muscle and reducing the workload on the heart. Cardiotonic medications, including Clift, are usually used in combination with other medications, such as diuretics, for maximum effect.

Clift contains the active substance meproscillarin, which is a cardiac glycoside. This substance increases the force of contraction of the heart muscle and reduces the load on the heart. In addition, Clift improves blood circulation and reduces swelling in the body.

Clift is manufactured in Germany by Knoll AG. This company specializes in the production of pharmaceuticals, including cardiotonic drugs. Knoll AG aims to produce high-quality medicines for the treatment of cardiovascular diseases.

In conclusion, Clift is a cardiotonic drug that is used to treat heart failure. It contains the active substance meproscillarin, which improves the contractile function of the heart and reduces the load on it. Clift is produced by the German company Knoll AG, which specializes in the production of pharmaceuticals for the treatment of cardiovascular diseases.